A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome

키워드

참고문헌 (91)

1. Rasquin Leon LI, "StatPearls" (2020), StatPearls Publishing
2. Coutinho EA, "The role of the brain in the pathogenesis and physiology of polycystic ovary syndrome(PCOS)", Med Sci(Basel), 7(8), pp.84~ (2019)
3. Azziz R, "PCOS : a diagnostic challenge", Reprod Biomed Online, 8(6), pp.644~648 (2004)
4. Sanchez-Garrido MA, "Metabolic dysfunction in polycystic ovary syndrome : Pathogenic role of androgen excess and potential therapeutic strategies", Mol Metab, 35, pp.100937~ (2020)
5. Ho CW, "Increased risk of polycystic ovary syndrome and it’s comorbidities in women with autoimmune thyroid disease", Int J Environ Res Public Health, 17(7), pp.2422~ (2020)
6. Aflatounian A, "Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model", J Endocrinol, 245(3), pp.381~395 (2020)
7. Walters KA, "New perspectives on the pathogenesis of PCOS : neuroendocrine origins", Trends Endocrinol Metab, 29(12), pp.841~852 (2018)
8. Zhang Y, "Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats", J Endocrinol, 246(3), pp.247~263 (2020)
9. Cox MJ, "Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model", Endocrinology, 161(7), pp.bqaa061~ (2020)
10. Brown J, "Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome", Cochrane Database Syst Rev, 12(12), pp.CD002249~ (2016)
11. Szilágyi A, "Endocrine characteristics of polycystic ovary syndrome(PCOS)", Indian J Exp Biol, 41(7), pp.694~700 (2003)
12. Pramodh S, "Exploration of lifestyle choices, reproductive health knowledge, and polycystic ovary syndrome(PCOS)awareness among female Emirati University students", Int J Womens Health, 12, pp.927~938 (2020)
13. Podfigurna A, "Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives(containing chlormadinone acetate versus drospirenone)", J Endocrinol Invest, 43(4), pp.483~492 (2020)
14. Gunning MN, "Cardiometabolic health in offspring of women with PCOS compared to healthy controls : a systematic review and individual participant data meta-analysis", Hum Reprod Update, 26(1), pp.103~117 (2020)
15. Wang H, "Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns", Arch Gynecol Obstet, 300(5), pp.1413~1421 (2019)
16. Feichtinger M, "Metabolic and reproductive consequences of the polycystic ovary syndrome(PCOS)", Wien Med Wochenschr, 166(3-4), pp.139~142 (2016)
17. Ranasinha S, "The association between polycystic ovary syndrome(PCOS)and metabolic syndrome : a statistical modelling approach", Clin Endocrinol(Oxf), 83(6), pp.879~887 (2015)
18. Moran LJ, "Predictors of lifestyle intervention attrition or weight loss success in women with polycystic ovary syndrome who are overweight or obese", Nutrients, 11(3), pp.492~ (2019)
19. Welt CK, "Clinical review : lifecycle of polycystic ovary syndrome(PCOS) : from in utero to menopause", J Clin Endocrinol Metab, 98(12), pp.4629~4638 (2013)
20. van Houten EL, "Reproductive and metabolic phenotype of a mouse model of PCOS", Endocrinology, 153(6), pp.2861~2869 (2012)
21. Scicchitano P, "Cardiovascular risk in women with PCOS", Int J Endocrinol Metab, 10(4), pp.611~618 (2012)
22. Teede HJ, "Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS", Endocrine, 30(1), pp.45~53 (2006)
23. Szosland K, "Metabolic characteristics of women diagnosed with polycystic ovary syndrome(PCOS)according to the Rotterdam criteria-our own experience", Neuro Endocrinol Lett, 39(6), pp.434~440 (2019)
24. Sachdeva G, "Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene", Indian J Endocrinol Metab, 23(3), pp.326~331 (2019)
25. Kakoly NS, "Cardiometabolic risks in PCOS : a review of the current state of knowledge", Expert Rev Endocrinol Metab, 14(1), pp.23~33 (2019)
26. Patel R, "High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome(PCOS)in rats", Reproduction, 155(2), pp.141~151 (2018)
27. Torchen LC, "Cardiometabolic risk in PCOS : more than a reproductive disorder", Curr Diab Rep, 17(12), pp.137~ (2017)
28. Kataoka J, "Weight management interventions in women with and without PCOS : a systematic review", Nutrients, 9(9), pp.996~ (2017)
29. Zhang H, "Highfat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS", Reproduction, 151(4), pp.431~441 (2016)
30. Sir-Petermann T, "Metabolic features across the female life span in women with PCOS", Curr Pharm Des, 22(36), pp.5515~5525 (2016)
31. Barry JA, "An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome(PCOS)", Med Hypotheses, 110, pp.42~45 (2018)
32. Jiskoot G, "A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome(PCOS) : a protocol for a randomized controlled trial", Reprod Health, 14(1), pp.34~ (2017)
33. Ilie IR, "Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS", Adv Clin Chem, 96, pp.85~135 (2020)
34. Azizi Kutenaee M, "The impact of depression, self-esteem, and body image on sleep quality in patients with PCOS : a crosssectional study", Sleep Breath, 24(3), pp.1027~1034 (2020)
35. Damone AL, "Depression, anxiety and perceived stress in women with and without PCOS : a community-based study", Psychol Med, 49(9), pp.1510~1520 (2019)
36. Karjula S, "Psychological distress is more prevalent in fertile age and premenopausal women with PCOS symptoms : 15-year follow-up", J Clin Endocrinol Metab, 102(6), pp.1861~1869 (2017)
37. Williams S, "‘Everything’s from the inside out with PCOS’ : exploring women’s experiences of living with polycystic ovary syndrome and co-morbidities through SkypeTM interviews", Health Psychol Open, 2(2), pp.2055102915603051~ (2015)
38. Bazarganipour F, "Health-related quality of life in patients with polycystic ovary syndrome(PCOS) : a model-based study of predictive factors", J Sex Med, 11(4), pp.1023~1032 (2014)
39. Dokras A, "Mood and anxiety disorders in women with PCOS", Steroids, 77(4), pp.338~341 (2012)
40. Mannerås L, "Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS", Am J Physiol Regul Integr Comp Physiol, 296(4), pp.R1124~R1131 (2009)
41. Witchel SF, "Curtailing PCOS", Pediatr Res, 87(2), pp.353~361 (2020)
42. Teede HJ, "Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome", Med J Aust, 209(S7), pp.S3~S8 (2018)
43. Azziz R, "Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome : an androgen excess and PCOS society resource", Hum Reprod, 34(11), pp.2254~2265 (2019)
44. Lie Fong S, "Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome(PCOS) : how to achieve weight loss in overweight and obese women with PCOS?", J Gynecol Obstet Hum Reprod, 50(6), pp.101894~ (2021)
45. Ferreira AS, "Role of dermatomes in the determination of therapeutic characteristics of channel acupoints : a similaritybased analysis of data compiled from literature", Chin Med, 8, pp.24~ (2013)
46. Ee C, "Acupuncture or auricular electro-acupuncture as adjuncts to lifestyle interventions for weight management in PCOS : protocol for a randomised controlled feasibility study", Pilot Feasibility Stud, 6, pp.53~ (2020)
47. Zhou F, "Acupuncture therapy for neurological diseases", pp.32~80 (2010), Springer
48. Lim CED, "Factors influencing the bioimpedance data in tissue segments along the three arm meridians : a pilot study", CellMed, 1(1), pp.e7~ (2011)
49. Sun J, "Effects of electroacupuncture on ovarian P450arom, P450c17α and mRNA expression induced by letrozole in PCOS rats", PLoS One, 8(11), pp.e79382~ (2013)
50. Li J, "Effect of electroacupuncture on the spindle and oocytes quality in patients with PCOS", Zhongguo Zhong Xi Yi Jie He Za Zhi, 35(3), pp.304~309 (2015)
51. Stener-Victorin E, "Changes in HbA1c and circulating and adipose tissue androgen levels in overweight-obese women with polycystic ovary syndrome in response to electroacupuncture", Obes Sci Pract, 2(4), pp.426~435 (2016)
52. Xu G, "Effects of electroacupuncture on ovarian expression of the androgen receptor and connexin 43 in rats with letrozole-induced polycystic ovaries", Evid Based Complement Alternat Med, 2020, pp.3608062~ (2020)
53. Feng Y, "Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5α-dihydrotestosterone-induced rat polycystic ovary syndrome model", Exp Physiol, 97(5), pp.651~662 (2012)
54. Xu L, "Acupuncture is not as effective as infertility treatment in women with PCOS", Evid Based Med, 22(6), pp.229~230 (2017)
55. Wang Q, "Manual acupuncture for the infertile female with polycystic ovary syndrome(PCOS) : study protocol for a randomized shamcontrolled trial", Trials, 20(1), pp.564~ (2019)
56. Zhang HL, "Acupuncture ameliorates negative emotion in PCOS patients : a randomized controlled trial", Zhongguo Zhen Jiu, 40(4), pp.385~390 (2020)
57. Stener-Victorin E, "Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries", Biol Reprod, 63(5), pp.1497~1503 (2000)
58. Manni L, "Effect of electro-acupuncture on ovarian expression of alpha(1)-and beta(2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries", Reprod Biol Endocrinol, 3, pp.21~ (2005)
59. Hickman FE, "Neurotrophin responsiveness of sympathetic neurons is regulated by rapid mobilization of the p75 receptor to the cell surface through TrkA activation of Arf6", J Neurosci, 38(24), pp.5606~5619 (2018)
60. Stener-Victorin E, "Acupuncture in polycystic ovary syndrome : current experimental and clinical evidence", J Neuroendocrinol, 20(3), pp.290~298 (2008)
61. Xiang S, "Effect of electroacupuncture on expression of IRS-1", PI3K, Chin J Integr Med, pp.2021, 27(5)[DOI]
62. Wu J, "Acupuncture therapy protects PCOS patients with diabetes by regulating miR-32-3p", PLA2G4A pathway, 2021, pp.13(8), 8819~8832
63. Zhao QY, "Effectiveness of herb-partitioned moxibustion combined with electroacupuncture on polycystic ovary syndrome in patients with symptom pattern of kidney deficiency and phlegm-dampne", J Tradit Chin Med, 41(6), pp.985~993 (2021)
64. Shi Y, "Efficacy of electroacupuncture in regulating the imbalance of AMH and FSH to improve follicle development and hyperandrogenism in PCOS rats", Biomed Pharmacother, 113, pp.108687~ (2019)
65. Tong X, "Ovarian innervation coupling with vascularity : the role of electro-acupuncture in follicular maturation in a rat model of polycystic ovary syndrome", Front Physiol, 11, pp.474~ (2020)
66. Peng Y, "Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats", Mol Med, 26(1), pp.73~ (2020)
67. Mannerås L, "Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome", Endocrinology, 149(7), pp.3559~3568 (2008)
68. Peng Y, "Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats : suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress", Biol Res, 53(1), pp.50~ (2020)
69. Johansson J, "Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome : different effects on muscle and fat tissue insulin signaling", PLoS One, 8(1), pp.e54357~ (2013)
70. Chen SZ, "An analysis on correlation between acupoint and target organs of acupuncture-moxibustion from the perspective of modern medical sciences", Zhen Ci Yan Jiu, 44(8), pp.620~624 (2019)
71. Chen H, "The efficacy of using acupuncture in managing polycystic ovarian syndrome", Curr Opin Obstet Gynecol, 31(6), pp.428~432 (2019)
72. Yang ES, "Ancient Chinese medicine and mechanistic evidence of acupuncture physiology", Pflugers Arch, 462(5), pp.645~653 (2011)
73. Lim CED, "Acupuncture for polycystic ovarian syndrome", Cochrane Database Syst Rev, 7(7), pp.CD007689~ (2019)
74. Lim CE, "Current evidence of acupuncture on polycystic ovarian syndrome", Gynecol Endocrinol, 26(6), pp.473~478 (2010)
75. Amir-Behghadami M, "Population, intervention, comparison, outcomes and study(PICOS)design as a framework to formulate eligibility criteria in systematic reviews", Emerg Med J, 37(6), pp.387~ (2020)
76. Banting LK, "Physical activity and mental health in women with polycystic ovary syndrome", BMC Womens Health, 14(1), pp.51~ (2014)
77. El-Mekawy HS, "Effect of laser acupuncture combined with a diet-exercise intervention on metabolic syndrome in post-menopausal women", J Adv Res, 6(5), pp.757~763 (2015)
78. Hong M, "Pcos-induced anxiety disorder treated mainly with acupuncture therapy : a randomized controlled trial", Acta Med Mediterr, 32, pp.1155~1158 (2016)
79. Wu XK, "Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial", JAMA, 317(24), pp.2502~2514 (2017)
80. El-Shamy FF, "Effectiveness of laser acupoints on women with polycystic ovarian syndrome : a randomized controlled trial", J Lasers Med Sci, 9(2), pp.113~120 (2018)
81. Cao Y, "The efficacy of Tung’s acupuncture for sex hormones in polycystic ovary syndrome : a randomized controlled trial", Complement Ther Med, 44, pp.182~188 (2019)
82. Wang Z, "Effects of electroacupuncture on anxiety and depression in unmarried patients with polycystic ovarian syndrome : secondary analysis of a pilot randomised controlled trial", Acupunct Med, 37(1), pp.40~46 (2019)
83. Pundir J, "Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome", Hum Reprod Update, 25(2), pp.243~256 (2019)
84. Hsu MI, "Changes in the PCOS phenotype with age", Steroids, 78(8), pp.761~766 (2013)
85. MacPherson H, "Revised standards for reporting interventions in clinical trials of acupuncture(STRICTA) : extending the CONSORT statement", Acupunct Relat Ther, 3(4), pp.35~46 (2015)
86. Bian Z, "Consolidated standards of reporting trials(CONSORT)for traditional Chinese medicine : current situation and future development", Front Med, 5(2), pp.171~177 (2011)
87. Torgerson DJ, "Designing randomised trials in health, education and the social sciences: an introduction" (2008), Palgrave Macmillan
88. Li R, "Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS : a cross-sectional study", BMC Endocr Disord, 14, pp.76~ (2014)
89. Hosseinpanah F, "Metabolic aspects of different phenotypes of polycystic ovary syndrome : Iranian PCOS prevalence study", Clin Endocrinol(Oxf), 81(1), pp.93~99 (2014)
90. Glintborg D, "Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark", Clin Endocrinol(Oxf), 73(6), pp.732~738 (2010)
91. Williams S, "The polycystic ovary syndrome quality of life scale(PCOSQOL) : development and preliminary validation", Health Psychol Open, 5(2), pp.2055102918788195~ (2018)

관련 논문AI추천